{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:24:54Z","timestamp":1789424694221,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","award":["US-VUM-11635"],"award-info":[{"award-number":["US-VUM-11635"]}],"id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.116054","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T19:38:28Z","timestamp":1766000308000},"page":"116054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effect of diroximel fumarate on gut dysbiosis and autoimmunity in the central nervous system"],"prefix":"10.1016","volume":"169","author":[{"given":"Sudhir Kumar","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shradha","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaritza","family":"Rosario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Tamar","family":"Kalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai L.","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhayl","family":"Dhib-Jalbut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.116054_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104500","article-title":"Comparative pharmacokinetics and bioavailability of monomethyl fumarate following a single oral dose of Bafiertam(R) (monomethyl fumarate) versus Vumerity(R) (diroximel fumarate)","volume":"70","author":"Rousseau","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.intimp.2025.116054_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122732","article-title":"New and old horizons for an ancient drug: pharmacokinetics, pharmacodynamics, and clinical perspectives of dimethyl fumarate","volume":"14","author":"Matteo","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.intimp.2025.116054_bb0015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00109-019-01761-5","article-title":"Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis","volume":"97","author":"Yadav","year":"2019","journal-title":"J. Mol. Med. (Berl)"},{"issue":"13","key":"10.1016\/j.intimp.2025.116054_bb0020","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1177\/1352458519881761","article-title":"Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study","volume":"26","author":"Naismith","year":"2020","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"key":"10.1016\/j.intimp.2025.116054_bb0025","doi-asserted-by":"crossref","unstructured":"R.T. Naismith, A. Wundes, T. Ziemssen, E. Jasinska, M.S. Freedman, A.J. Lembo, K. Selmaj, I. Bidollari, H. Chen, J. Hanna, R. Leigh-Pemberton, M. Lopez-Bresnahan, J. Lyons, C. Miller, D. Rezendes, J.S. Wolinsky, E.-M.S.S.G. The, Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing\u2013Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study, CNS Drugs 34(2) (2020) 185\u2013196.","DOI":"10.1007\/s40263-020-00700-0"},{"key":"10.1016\/j.intimp.2025.116054_bb0030","doi-asserted-by":"crossref","DOI":"10.1177\/1756286421993999","article-title":"Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study","volume":"14","author":"Wundes","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"9","key":"10.1016\/j.intimp.2025.116054_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137429","article-title":"Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters","volume":"10","author":"Miyake","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.intimp.2025.116054_bb0040","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.1038\/ncomms12015","article-title":"Alterations of the human gut microbiome in multiple sclerosis","volume":"7","author":"Jangi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.116054_bb0045","doi-asserted-by":"crossref","first-page":"28484","DOI":"10.1038\/srep28484","article-title":"Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2025.116054_bb0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrmicro2989","article-title":"\u2018Blooming\u2019 in the gut: how dysbiosis might contribute to pathogen evolution","volume":"11","author":"Stecher","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"issue":"50","key":"10.1016\/j.intimp.2025.116054_bb0055","doi-asserted-by":"crossref","first-page":"18129","DOI":"10.1073\/pnas.0505256102","article-title":"Reduced Paneth cell alpha-defensins in ileal Crohn\u2019s disease","volume":"102","author":"Wehkamp","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2025.116054_bb0060","article-title":"Antimicrobial peptides in gastrointestinal inflammation","volume":"2010","author":"Jager","year":"2010","journal-title":"Int J Inflam"},{"issue":"3","key":"10.1016\/j.intimp.2025.116054_bb0065","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1164\/ajrccm.160.3.9807080","article-title":"Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria","volume":"160","author":"Meduri","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.intimp.2025.116054_bb0070","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.130048","article-title":"Pro-inflammatory cytokines can act as intracellular modulators of commensal bacterial virulence","volume":"3","author":"Mahdavi","year":"2013","journal-title":"Open Biol."},{"issue":"40","key":"10.1016\/j.intimp.2025.116054_bb0075","doi-asserted-by":"crossref","first-page":"10719","DOI":"10.1073\/pnas.1711233114","article-title":"Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice","volume":"114","author":"Berer","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"40","key":"10.1016\/j.intimp.2025.116054_bb0080","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1073\/pnas.1711235114","article-title":"Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.intimp.2025.116054_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1700492","article-title":"High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis","volume":"3","author":"Cosorich","year":"2017","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.intimp.2025.116054_bb0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.celrep.2019.09.002","article-title":"Disrupting myelin-specific Th17 cell gut homing confers protection in an adoptive transfer experimental autoimmune encephalomyelitis","volume":"29","author":"Duc","year":"2019","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.intimp.2025.116054_bb0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.intimp.2025.116054_bb0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: high-resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.intimp.2025.116054_bb0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.intimp.2025.116054_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/msj.20249","article-title":"Immunologic aspects of multiple sclerosis","volume":"78","author":"Boppana","year":"2011","journal-title":"Mt. Sinai J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.116054_bb0115","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/1352458516652498","article-title":"Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study","volume":"23","author":"Buscarinu","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.intimp.2025.116054_bb0120","doi-asserted-by":"crossref","first-page":"1015372","DOI":"10.3389\/fimmu.2022.1015372","article-title":"Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis","volume":"13","author":"Yadav","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2025.116054_bb0125","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/DCR.0b013e3181f1e620","article-title":"Desulfovibrio bacterial species are increased in ulcerative colitis","volume":"53","author":"Rowan","year":"2010","journal-title":"Dis. Colon Rectum"},{"issue":"7","key":"10.1016\/j.intimp.2025.116054_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11071772","article-title":"Desulfovibrio in the gut: the enemy within?","volume":"11","author":"Singh","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.intimp.2025.116054_bb0135","doi-asserted-by":"crossref","unstructured":"M. Nakajima, K. Arimatsu, T. Kato, Y. Matsuda, T. Minagawa, N. Takahashi, H. Ohno, K. Yamazaki, Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver, PLoS One 10(7) (2015) e0134234.","DOI":"10.1371\/journal.pone.0134234"},{"issue":"9","key":"10.1016\/j.intimp.2025.116054_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106335","article-title":"Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells","volume":"9","author":"Nouri","year":"2014","journal-title":"PloS One"},{"issue":"22","key":"10.1016\/j.intimp.2025.116054_bb0145","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1212\/WNL.0000000000003391","article-title":"Gram-negative bacterial molecules associate with Alzheimer disease pathology","volume":"87","author":"Zhan","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2025.116054_bb0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-2094-5-37","article-title":"Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation","volume":"5","author":"Lee","year":"2008","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.intimp.2025.116054_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18094621","article-title":"Detection of Dysbiosis and increased intestinal permeability in Brazilian patients with relapsing-remitting multiple sclerosis","volume":"18","author":"Pellizoni","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"44","key":"10.1016\/j.intimp.2025.116054_bb0160","doi-asserted-by":"crossref","first-page":"E9318","DOI":"10.1073\/pnas.1615715114","article-title":"Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood","volume":"114","author":"Yadav","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2025.116054_bb0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fimmu.2015.00223","article-title":"Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability","volume":"6","author":"de Punder","year":"2015","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2025.116054_bb0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40263-020-00700-0","article-title":"Diroximel fumarate demonstrates an improved gastrointestinal tolerability profile compared with dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: results from the randomized, double-blind, phase III EVOLVE-MS-2 study","volume":"34","author":"R.T. Naismith, A. Wundes, T. Ziemssen, E. Jasinska, M.S. Freedman, A.J. Lembo, K. Selmaj, I. Bidollari, H. Chen, J. Hanna, R. Leigh-Pemberton, M. Lopez-Bresnahan, J. Lyons, C. Miller, D. Rezendes, J.S. Wolinsky, E.-M.-S. Group","year":"2020","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1016\/j.intimp.2025.116054_bb0175","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/acn3.251","article-title":"Dimethyl fumarate inhibits integrin alpha4 expression in multiple sclerosis models","volume":"2","author":"Kihara","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.intimp.2025.116054_bb0180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fimmu.2014.00060","article-title":"Regulation of intestinal immune responses through TLR activation: implications for pro- and prebiotics","volume":"5","author":"de Kivit","year":"2014","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.116054_bb0185","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/hep.27489","article-title":"Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice","volume":"61","author":"Chen","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2025.116054_bb0190","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10620-018-5313-z","article-title":"Proinflammatory sulfur-reducing Bacteria are more abundant in colonic biopsies of patients with microscopic colitis compared to healthy controls","volume":"64","author":"Millien","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.intimp.2025.116054_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.652617","article-title":"Desulfovibrio Bacteria are associated with Parkinson's disease","volume":"11","author":"Murros","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.intimp.2025.116054_bb0200","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0016-5085(93)91016-B","article-title":"Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis","volume":"104","author":"Roediger","year":"1993","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.intimp.2025.116054_bb0205","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40168-023-01722-8","article-title":"Desulfovibrio vulgaris interacts with novel gut epithelial immune receptor LRRC19 and exacerbates colitis","volume":"12","author":"Xie","year":"2024","journal-title":"Microbiome"},{"issue":"11","key":"10.1016\/j.intimp.2025.116054_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112306","article-title":"The C-C chemokines CCL17 and CCL22 and their receptor CCR4 in CNS autoimmunity","volume":"18","author":"Scheu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2025.116054_bb0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.imlet.2012.04.003","article-title":"Current status of chemokine receptor inhibitors in development","volume":"145","author":"Allegretti","year":"2012","journal-title":"Immunol. Lett."},{"issue":"10","key":"10.1016\/j.intimp.2025.116054_bb0220","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/1028415X.2018.1436237","article-title":"Vitamin D down-regulates the expression of some Th17 cell-related cytokines, key inflammatory chemokines, and chemokine receptors in experimental autoimmune encephalomyelitis","volume":"22","author":"Jafarzadeh","year":"2019","journal-title":"Nutr. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2025.116054_bb0225","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12974-018-1249-7","article-title":"Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis","volume":"15","author":"Hakansson","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.intimp.2025.116054_bb0230","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.3892\/mmr.2017.6492","article-title":"SCRG1 suppresses LPS-induced CCL22 production through ERK1\/2 activation in mouse macrophage Raw264.7 cells","volume":"15","author":"Inoue","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2025.116054_bb0235","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41598-018-37894-9","article-title":"A transcription factor PU.1 is critical for Ccl22 gene expression in dendritic cells and macrophages","volume":"9","author":"Yashiro","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2025.116054_bb0240","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bbrc.2015.03.098","article-title":"LPS-miR-34a-CCL22 axis contributes to regulatory T cell recruitment in periapical lesions","volume":"460","author":"He","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T18:53:25Z","timestamp":1773946405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925020430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":48,"alternative-id":["S1567576925020430"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116054","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of diroximel fumarate on gut dysbiosis and autoimmunity in the central nervous system","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116054"}}